To evaluate ALS pathology at this stage, we assessed astrocyte reactivity by evaluating the number of astrocytes staining for glial fibrillary acidic protein (GFAP) [48] and microglial activation by detecting the ionized calcium-binding adaptor molecule 1 (Iba1) marker [49]. Here, AIF1 is linked to amyotrophic lateral sclerosis.